Do medical marijuana laws reduce addictions and deaths related to pain killers?

Journal of Health Economics

Volumn 58, Issue , 2018, Pages 29-42

  Powell, David ^a   Pacula, Rosalie Liccardo ^a,b   Jacobson, Mireille ^b,c  

^a RAND CORPORATION   (United States)

^b NATIONAL BUREAU OF ECONOMIC RESEARCH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dispensaries; Medical marijuana; Mortality; Opioids; Pain killers; Substance abuse

Indexed keywords

FENTANYL; HYDROCODONE; HYDROMORPHONE; MEDICAL CANNABIS; METHADONE; OPIATE; OXYCODONE; PETHIDINE;

DRUG; DRUG USER; MORTALITY RISK;

ARTICLE; DRUG FATALITY; DRUG OVERDOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEALTH CARE ACCESS; HEALTH CARE FACILITY; HUMAN; LAW; MEDICAID; MEDICARE; MEDICOLEGAL ASPECT; OPIATE ADDICTION; PAIN; PRESCRIPTION; CANNABIS SMOKING; LEGISLATION AND JURISPRUDENCE; MORTALITY; RISK REDUCTION; UNITED STATES;

CANNABIS SATIVA;

HUMANS; MARIJUANA SMOKING; MEDICAL MARIJUANA; OPIOID-RELATED DISORDERS; PAIN; RISK REDUCTION BEHAVIOR; UNITED STATES;

EID: 85041390959     PISSN: 01676296     EISSN: 18791646     Source Type: Journal    
DOI: 10.1016/j.jhealeco.2017.12.007     Document Type: Article

References (52)

1. Alpert, A. Powell, D. Pacula, R.L. Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent Opioids, Am. Econ. J.: Econ. Policy forthcoming.
2. Anderson, D.M., Hansen, B., Rees, D.I., Medical marijuana laws, traffic fatalities, and alcohol consumption. J. Law Econ. 56:2 (2013), 333–369.
3. Anderson, D.M., Hansen, B., Rees, D.I., Medical marijuana laws and teen marijuana use. Am. Law Econ. Rev. 17:2 (2015), 495–528.
4. Anderson, D.M., Does information matter? The effect of the Meth Project on meth use among youths. J. Health Econ. 29:5 (2010), 732–742.
5. Bachhuber, M.A., Saloner, B., Cunningham, C.O., Barry, C.L., Medical cannabis laws and opiate analgesic overdose mortality in the United States, 1999–2010. JAMA Inter. Med., 2014.
6. Borgelt, L.M., Franson, K.L., Nussbaum, A.M., Wang, G.S., The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy 33 (2013), 195–209.
7. Bowles, D.W., Persons registered for medical marijuana in the United States. J. Palliat. Med. 15:1 (2012), 9–11.
8. Bradford, A.C., Bradford, W.D., Medical marijuana laws reduce prescription medication use in Medicare Part D. Health Aff. (Millwood) 35:7 (2016), 1230–1236.
9. Bradford, A.C., Bradford, W.D., Medical marijuana laws may Be associated with a decline In the number of prescriptions for medicaid enrollees. Health Aff. (Millwood), 2017, 10.1377/hlthaff.2016.1135 (on-line publication).
10. Brady, J.E., Wunsch, H., DiMaggio, C., Lang, B.H., Giglio, J., Li, G., Prescription drug monitoring and dispensing of prescription opioids. Public Health Rep. 129 (2014), 139–147.
11. Buchmueller, T.C., Carey, C., The effect of prescription drug monitoring programs on opioid utilization in medicare. Am. Econ. J.: Econ. Policy, 2017 (Forthcoming).
12. Centers for Disease Control and Prevention, Vital signs: overdoses of prescription opioid pain relievers –United states, 1999–2008. Morbid. Mortal. Weekly Rep. 60:43 (2011), 1487–1492.
13. Case, A., Deaton, A., Rising morbidity and mortality in midlife among white non-hispanic americans in the 21 st century. Proceedings of the National Academy of Sciences, 2015 http://www.pnas.org/content/early/2015/10/29/1518393112.full.pdf.
14. Case, A., Deaton, A., Mortality and morbidity in the 21 st century. Brookings Papers on Economic Activity, Conference Draft, 2017 https://www.brookings.edu/wp-content/uploads/2017/03/6_casedeaton.pdf.
15. Choi, A., The impact of medical marijuana laws on marijuana use and other risky health behaviors. Health Healthcare Am.: Econ. Policy, 2014 (Ashecon).
16. Chriqui, J.F., Pacula, R.L., McBride, D.C., Reichmann, D.A., VanderWaal, C.J., Terry-McElrath, Y., Illicit Drug Policies: Selected Laws from the 50 States and the District of Columbia. 2002, Andrews University, Berrien Springs, MI.
17. Chu, Y.W.L., The effects of medical marijuana laws on illegal marijuana use. J. Health Econ. 38 (2014), 43–61.
18. Davis, J.M., Mendelson, B., Berkes, J.J., Suleta, K., Corsi, K.F., Booth, R.E., Public health effects of medical marijuana legalization in colorado. Am. J. Prev. Med. 50:3 (2016), 373–379.
19. Freisthler, B., Gruenewald, P.J., Examining the relationship between the physical availability of medical marijuana and marijuana use across fifty California cities. Drug Alcohol Depend. 143 (2014), 244–250.
20. Ghosh, T.S., Van Dyke, M., Maffey, A., Whitley, E., Erpelding, D., Wolk, L., Medical marijuana's public health lessons—implications for retail marijuana in Colorado. New Engl. J. Med. 372:11 (2015), 991–993.
21. Hall, W., Pacula, R.L., Cannabis Use and Dependence: Public Health and Public Policy. 2003, Cambridge University Press.
22. Hedegaard, H., Warner, M., Minino, A.M., Drug Overdose Deaths in the United States, 1999–2015. NCHS Data Brief No 273. 2017, National Center for Health Statistics, Hyattsville, MD.
23. Jones, C.M., Mack, K.A., Paulozzi, L.J., Pharmaceutical overdose deaths, United States 2010. JAMA 309:7 (2013), 657–659.
24. Kim, J.H., Santaella-Tenorio, J., Mauro, C., et al. State medical marijuana laws and the prevalence of opioids detected among fatally injured drivers. Am. J. Public Health 106:11 (2016), 2032–2037.
25. Klieger, S.B., Allen, L., Pacula, R.L., Ibrahim, J.K., Burris, S., Mapping medical marijuana: state laws regulating patients, product safety and dispensaries. Addiction, 2016 forthcoming.
26. Leung, L., Cannabis and its derivatives: review of medical use. J. Am. Board Fami. Med. 24:4 (2011), 452–462.
27. Lynch, M.E., Cambell, F., Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br. J. Clin. Pharmacol. 72 (2011), 735–744.
28. Lynne-Landsman, S.D., Livingston, M.D., Wagenaar, A.C., Effects of state medical marijuana laws on adolescent marijuana use. Am. J. Public Health 103:8 (2013), 1500–1506.
29. Mark, T.L., Levit, K.R., Vandivort-Warren, R., Buck, J.A., Coffey, R.M., Changes in US spending on mental health and substance abuse treatment, 1986–2005, and implications for policy. Health Aff. (Millwood) 30:2 (2011), 284–292.
30. Martin-Sanchez, E., Furukawa, T.A., Taylor, J., Martin, J.L., Systematic review and metanalysis of cannabis treatment for chronic pain. Pain Med. 10 (2009), 1353–1368.
31. Murphy, S.L., Xu, J., Kochanek, K.D., Deaths: final data for 2010. Nat. Vital Stat. Rep. 61:May (4) (2013), 1–118.
32. Nunberg, H., Kilmer, B., Pacula, R.L., Burgdorf, J.R., An analysis of applicants presenting to a medical marijuana specialty practice in california. J. Drug Policy Analys., 4(1), 2011, 10.2202/1941-2851.1017.
33. Ogden, D.W., Investigations And Prosecutions in States Authorizing the Medical Use of Marijuana. Memorandum For Selected United States Attorneys. 2009, U.S. Department of Justice, Office of the Deputy Attorney, Washington, D.C.
34. Pacula, R.L., Smart, R., Effects of changes in marijuana laws on marijuana use and disorders: medical marijuana and marijuana legalization. Annu. Rev. Clin. Psychol. 13:1 (2017), 397–419.
35. Pacula, R.L., Chriqui, J.F., Reichmann, D.A., Terry-McElrath, Y.M., State medical marijuana laws: understanding the laws and their limitations. J. Public Health Policy 23:4 (2002), 413–439.
36. Pacula, R.L., Kilmer, B., Grossman, M., Chaloupka, F., Risks and prices: the role of user sanctions in marijuana markets. B.E. J. Econ. Analys. Policy, 10(1), 2010 (Contributions).
37. Pacula, R.L., Boustead, A., Hunt, P., Words can be deceiving: a review of variation among legally effective medical marijuana laws in the United States. J. Drug Policy Analys., 2014, 10.1515/jdpa-2014-0001 ISSN (Online) 1941–2851, ISSN (Print) 2194–6337, May 2014.
38. Pacula, R.L., Powell, D., Heaton, P., Sevigny, E.L., Assessing the effects of medical marijuana laws on marijuana use: the devil is in the details. J. Policy Anal. Manage. 34:1 (2015), 7–31.
39. Pardo, B., Do more robust prescription drug monitoring programs reduce prescription opioid overdose?. Addiction, 2017, 10.1111/add.13741 (Published online ahead of print, February 8, 2017).
40. rrPatrick, S.W., Fry, C.E., Jones, T.F., Buntin, M.B., Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates. Health Aff. (Millwood) 35:7 (2016), 1324–1332.
41. Paulozzi, L.J., Ryan, G.W., Opioid analgesics and rates of fatal drug poisoning in the United States. Am. J. Prev. Med. 31:6 (2006), 506–511.
42. Paulozzi, L.J., Kilbourne, E.M., Desai, H.A., Prescription drug monitoring programs and death rates from drug overdose. Pain Med. 12 (2011), 747–754.
43. Rudd, R.A., Aleshire, N., Zibbell, J.E., Matthew Gladden, R., Increases in drug and opioid overdose deaths—United States, 2000–2014. Am. J. Transplant. 16:4 (2016), 1323–1327.
44. Rutter, Ali, Smith, Strashny, Factors associated with substance use treatment completion in residential facilities. Drug Alcohol Depend. 154 (2015), 291–295.
45. Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Behavioral Health Statistics and Quality. Treatment Episode Data Set (TEDS): 2005–2015. National Admissions to Substance Abuse Treatment Services. BHSIS Series S-91, HHS Publication No. (SMA) 17–5037. Rockville, MD : Substance Abuse and Mental Health Services Administration, 2017.
46. Santos Silva, J., Tenreyro, S., The log of gravity. Rev. Econ. Statis. 88:4 (2006), 641–658.
47. Sevigny, E.L., Pacula, R.L., Heaton, P., The effects of medical marijuana laws on potency. Int. J. Drug Policy 25:2 (2014), 308–319.
48. Shi, Y., Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever. Drug Alcohol Depend. 173 (2017), 144–150.
49. Smart, R., Essays on the Effects of Medical Marijuana Laws. 2016, University of California, 2016, Los Angeles.
50. Wen, H., Hockenberry, J.M., Cummings, J.R., The effect of medical marijuana laws on adolescent and adult use of marijuana, alcohol: and other substances. J. Health Econ. 42 (2015), 64–80.
51. rrWilliams, A.R., Olfson, M., Kim, J.H., Martins, S.S., Kleber, H.D., Older, less regulated medical marijuana programs have much greater enrollment rates than newer medicalized programs. Health Aff. (Millwood) 35:3 (2016), 480–488.
52. Wooldridge, Jeffrey M., second ed. Econometric Analyses of Cross Section and Panel Data, vol. 1, 2010, MIT Press.